Froedtert and the Medical College of Wisconsin Froedtert Hospital in Milwaukee became the next clinical site for InVivo Therapeutics' spinal cord injury treatment investigational device exemption clinical trial.
The Latest
Orthopedic injuries are a hazard of the job for professional athletes. Yet, most athletes are able to undergo treatment — sometimes surgery — and then return to an elite level of play.
DJO Global reported net sales growth during the fourth quarter of 2014, as well as for the full year, but also posted a net loss.
The National Football League suspended helmet sensor use in a voluntary pilot program designed for researchers to collect data about how often, and hard, players are hit in the head, according to a New York Times report.
Vertex Pharmaceuticals recently acquired a spinal cord injury repair drug from BioAxome Bioseicneces, which could be the company's saving grace after the hepatitis C drug Vertex took a gamble on failed, according to an Xconomy report.
There have now been more than 1,000 partial knee replacements performed using the Navio Robotic Surgical System from Blue Belt Technologies.
The global arthroscopic devices market is growing as more surgeries are now performed through less invasive procedures, according to a new report from Medical Market Research.
Texas Rangers team physician Keith Meister, MD, will perform surgery on the team's second baseman Jurickson Profar's right shoulder, according to a St. Louis Post-Dispatch report.
A new study published in the Journal of Spinal Disorders and Techniques examines whether CT scans overestimated fusion rates after anterior cervical discectomy and fusion.
Here are 10 spine and neurosurgeons in the news over this past week.